Beyond US tech stocks: three global stars to buy now
There is much to like about the US tech giants, says professional investor Alec Cutler of Orbis Investments highlights. But there are many other excellent businesses out there trading at much more attractive valuations. Here are three of his favourites.
Stockmarket indices can be a poor reflection of reality. Mega-cap technology stocks in the US have had an overwhelming impact on returns, but this obscures the fact that the average global stock has only recently recovered from a hidden bear market dating back to early 2018.
While there is much to like about the US tech giants – deep “moats” (entrenched competitive advantages that fend off potential rivals), high returns on capital, piles of cash and appealing long-term growth potential – there are excellent businesses out there trading at much more attractive valuations. Great investment ideas come in many different shapes and sizes and it always pays to cast a wide net.
A top Taiwanese chip maker
Taiwan Semiconductor Manufacturing Company (Taipei: 2330) has many of the same attractive fundamentals as its US peers. TSMC is more dominant in chip manufacturing than its largest customer, Apple, is in smartphones, yet it trades at a substantial discount to its American client. As the world’s dominant manufacturer of logic semiconductors, TSMC stands to benefit from powerful long-term tailwinds in artificial intelligence (AI), cloud-computing and 5G-wireless broadband.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
None of these technologies will be possible without leading-edge semiconductors and TSMC is one of only two remaining players who can make them. We believe TSMC can continue to grow its earnings at around 15% per annum over the long term while maintaining its very high returns on equity (a key gauge of profitability).
A leading US health insurer
Having a new resident in the White House almost always leads to fresh debate about the future of the US healthcare system. Historically this has been a source of opportunity for investors. Leading US health insurers such as Anthem (NYSE: ANTM) have rarely traded at demanding valuations, despite delivering superior fundamentals.
Since 2000, Anthem has delivered earnings-per-share growth of 16% a year compared with 6% for the S&P 500 index. The combined tailwinds of an ageing population, rising incomes and expansion of health coverage to more people should continue to fuel above-average profit growth. There will no doubt be considerable volatility and heated political rhetoric, but history has shown that changes in the US healthcare sector have been gradual rather than revolutionary, and the likes of Anthem are an important part of the system.
Luxury car group roars ahead
BMW (Frankfurt: BMW) is one of the world’s highest-quality car manufacturers. Of the 1,600 companies in the FTSE World Index ex-US in 1990, fewer than 80 have delivered earnings-per-share growth of more than 10% per annum since then, and BMW is one of them. It has generated a return on equity of 15% over the long term and has compounded earnings at a rate well above most businesses in any sector for several decades.
It is a remarkable achievement and a testament to the family-controlled company’s discipline, culture and premium brand value. The pandemic has been a setback in the short term and BMW will also need to adjust to a future where electric vehicles are more common, but we are confident that the group has the expertise and financial strength to navigate these headwinds successfully over the long term.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alec Cutler joined Orbis Investment in 2004. Based in Bermuda, he leads the multi-asset team, is one of the portfolio managers for the Orbis Global Balanced Strategy, and has overall responsibility for the strategy. He previously worked for ten years at Brandywine Asset Management LLC managing the Relative Value strategy, co-managing the Large Cap Value area and co-managing the firm as a member of the executive committee.
Alec holds a Bachelor of Science degree in naval architecture from the United States Naval Academy, a Master of Business Administration from the Wharton School of the University of Pennsylvania, and is a Chartered Financial Analyst.
-
Twenty 'finfluencers' questioned under caution by the UK regulator
The individuals were interviewed voluntarily using the Financial Conduct Authority’s criminal powers
By Chris Newlands Published
-
Number of ISA millionaires triples in three years
The number of people with £1 million in their ISAs has tripled in three years to reach 3,180. But could next week’s Budget put an end to future ISA millionaires?
By Ruth Emery Published
-
Should you invest in Canada?
Canada presents a compelling opportunity for investors who want to look beyond the US. Greg Eckel of Canadian General Investments highlights four favourites
By Greg Eckel Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Will European stocks bounce back?
European stocks have looked unattractive for some time – will they bounce back?
By Alex Rankine Published
-
British American Tobacco goes smokeless – can it survive?
British American Tobacco’s core product is struggling, but new areas bode well, says Bruce Packard
By Bruce Packard Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
LSL Property Services: a profit-machine in the property sector
LSL covers every area of the residential real estate market and should thrive after its shake-up
By Rupert Hargreaves Published